These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3581774)

  • 1. In vivo chemotaxis of rat leucocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP).
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1987; 10(1):33-9. PubMed ID: 3581774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucocyte migration into cotton pellets: a new in vivo method for the study of chemotaxis and leucocytic migration.
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1986; 9(1):79-88. PubMed ID: 3769443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal protein A (SpA): a potent in vivo chemotactic agent for rat leucocytes.
    Onyia KA
    Comp Immunol Microbiol Infect Dis; 1988; 11(1):21-6. PubMed ID: 3383551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
    Quitt M; Torres M; McGuire W; Beyer L; Coates TD
    J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 alpha (IL-1 alpha) and N-formyl-methionyl-leucyl-phenylalanine (FMLP) as potential inducers of supravital chemotaxis.
    Grellner W; Madea B; Kruppenbacher JP; Dimmeler S
    Int J Legal Med; 1996; 109(3):130-3. PubMed ID: 8956986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Elfman F; Lobo E
    J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Perianin A; Labro MT; Hakim J
    Biochem Pharmacol; 1982 Oct; 31(19):3071-6. PubMed ID: 6756410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC; Hughes BJ; Smith CW
    J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
    Tonnesen MG; Smedly LA; Henson PM
    J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oriented migration of rat polymorphonucleocytes induced by 4-hydroxynonenal and formylmethionyl-leucyl-phenylalanine].
    Curzio M; Torriello MV; Dianzani MU
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1672-8. PubMed ID: 6897768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
    de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
    J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
    Partsch G; Schwarzer C
    J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anethole and eugenol reduce in vitro and in vivo leukocyte migration induced by fMLP, LTB4, and carrageenan.
    Estevão-Silva CF; Kummer R; Fachini-Queiroz FC; Grespan R; Nogueira de Melo GA; Baroni S; Cuman RK; Bersani-Amado CA
    J Nat Med; 2014 Jul; 68(3):567-75. PubMed ID: 24789168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in man.
    Peters MJ; Breslin AB; Kemp AS; Chu J; Berend N
    Thorax; 1992 Apr; 47(4):284-7. PubMed ID: 1585293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
    Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB
    Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.